---
title: "GE JIAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac
json: https://whiteintel.dev/api/public/dossier/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac
identifier: sec:0001413815
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GE JIAN

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001413815`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac  

## Ownership & control

### Holdings / subsidiaries

- **GENESIS PHARMACEUTICALS ENTERPRISES, INC.** (director) — https://whiteintel.dev/entity/29d54a98-5fad-5a7d-b7cd-36226b5f7f91

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GE JIAN**. Human view: https://whiteintel.dev/entity/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac · Structured JSON: https://whiteintel.dev/api/public/dossier/f634cd02-d7ac-50bd-b9af-cc238d2fd8ac._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._